Aurinia Pharmaceuticals Inc
看多

Consolidating close to the resistance.

160
Given its recent FDA approvals ir.auriniapharma.com/press-releases/detail/210/fda-approves-aurinia-pharmaceuticals-lupkynis , we will see this breaking out in short time and head towards $30.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。